Showing 841 - 860 of 2483 results
More than 3,200 solar panels have been installed across the rooftops of the Australian Nuclear Science and Technology Organisation’s (ANSTO) Australian Synchrotron in Clayton, offsetting enough power to light up the whole MCG for more than five years.
During the scheduled shutdown of the OPAL multi-purpose reactor, an ANSTO engineering and project team has installed a new safety shutdown instrumentation and control system (I&C).
ANSTO to ensure ultra-low radiation environment in newly-funded Stawell Underground Physics Laboratory.
ANSTO hosted an international meeting of Expert and Policy group members for Generation IV Forum (GIF).
ANSTO’s National Deuteration Facility has provided deuterated cholesterol for international research to gain a better understanding of how the Spike protein of the COVID virus, SARS-Co-V-2, infects human cells through a membrane fusion mechanism.
ANSTO scientist, Dr Klaus Wilcken of the Centre for Accelerator Science, used cosmogenic nuclide dating to determine the ages of layered sand and gravel samples, in which seven footprints of the flightless bird, the moa, were found on the South Island in New Zealand in 2019.
The protein mapping workhorses of the Australian Synchrotron, Macromolecular and Microfocus crystallography beamlines, MX1 and 2, continue to support important biomedical research in the development of vaccines and new therapeutics.
Modified component of green tea promises potential neuroblastoma treatment.
Bushfires in proximity to ANSTO during the 2018 bushfires.
Nuclear techniques used in investigation of a new class of micro and nanoscale zinc fertilisers.
Close to 3000 members of the public decided to have a look at a building that is shaped like a doughnut, is as big as a football field and creates light more powerful than the sun when the Australian Synchrotron held its bi-annual Open Day held on Sunday, 16 October.
Technology for enclosed spaces recently won global COVID19 NASA hackathon
Cyclotek and ANSTO have announced the launch of a Joint Venture (JV), to establish Australia’s first GMP (Good Manufacturing Practice) theranostics facility starting in Melbourne, Australia.